Connect your AI

Microbot Medical MBOT Raw materials and supplies inventory, gross

Raw materials and supplies inventory, gross at other companies

Duke EnergyDUK

$3.39B+9.8%

Raytheon TechnologiesRTX

$4.98B+10.8%

International Flavors & FragrancesIFF

$737M-3.0%

The J.M. Smucker CompanySJM

$542.4M+2.5%

Cabot CorporationCBT

$144M-2.0%

Tarsus Pharmaceuticals, Inc.TARS

$2.53M-0.2%

Other financials

Income statement

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's raw materials and supplies inventory, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Microbot Medical's raw materials and supplies inventory, gross?: Microbot Medical (MBOT) reported raw materials and supplies inventory, gross of $416K in Q4 2025.